Release Date:
January 12, 2012
Expiration Date:
January 31, 2013
Topics:
Specialty:
Family Medicine / General Practice
Internal Medicine
Nephrology
Urology
Profession:
Format:
Clinical Review
Credits:
1.00 /
AMA PRA Category 1 Credit(s)TM
Estimated Time to Complete:
1 hour
|
Program Description:
Robotic partial nephrectomy (RPN) is an emerging option for patients desiring minimally-invasive treatment for localized renal tumors. Short-term outcomes from early institutional experiences have confirmed the safety and feasibility of RPN, even for anatomically complex tumors. Although current data are limited, comparative series with laparoscopic partial nephrectomy suggest a reduced warm ischemia time and decreased learning curve using the robotic platform, which may extend the benefits of minimally invasive nephron-sparing surgery to an increasing number of urologists without significant laparoscopic experience.
Activity Objectives:
After completing the activity, the participant should be better able to: - Discuss emerging treatment options for patients presenting with renal tumors.
- Evaluate the pros and cons of the robotic platform to date.
- Examine warm ischemia time and the best threshold for the preservation of renal function.
TARGET AUDIENCE:This activity has been designed to meet the educational needs of urologists and nephrologists involved in the treatment of patients with kidney cancer.
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
1.00
|
AMA PRA Category 1 Credit(s)TM
|
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and Haymarket Media, Inc. MER is accredited by the ACCME to provide continuing medical education for physicians.
|
Medical Education Resources designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
Faculty:
Rosalia Viterbo, MD
Assistant Professor
Division of Urologic Oncology
Fox Chase Cancer Center
Philadelphia, PA
Disclosures:
Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not a commercial interest.
Faculty Disclosures
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
Rosalia Viterbo, MD, has no financial relationships to disclose.
Publishing Staff Disclosures
The content managers, Jody A. Charnow and Marina Galanakis of Haymarket Media Inc., and Victoria C. Smith, MD, of Medical Education Resources, have disclosed that they have no relevant financial relationships or conflicts of interest relating directly or indirectly to this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Medical Education Resources, Inc. (MER), and Haymarket Medical Education (HME) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of MER and HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources or Haymarket Media, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources or Haymarket Media, Inc. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Privacy Policy
To view the myCME privacy policy, please click here. To view the Medical Education Resources privacy policy, please click here.
Accredited Provider:
This program is sponsored by Medical Education Resources, Inc., and produced by Haymarket Medical Education.
 
If you have any questions relating to the accreditation of this activity, please contact:
Medical Education Resources, Inc.
1500 West Canal Court
Littleton, CO 80120-5615
Tel: 1-800-421-3756
E-mail: info@cmepartner.org
Instructions:
To obtain credit, a post-test score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.
|